We provide you with 20 years of free, institutional-grade data for STOK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of STOK. Explore the full financial landscape of STOK stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$2,355,775
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Allan Jonathan | Sale | -22,117 | $20 | $442,340 | 2025-09-03 |
| Allan Jonathan | Derivatives Exercise | 10,000 | 2025-09-03 | ||
| Ticho Barry | Sale | -5,501 | $19.87 | $109,325 | 2025-09-03 |
| Kaye Edward M. MD | Sale | -61,885 | $20 | $1,237,700 | 2025-09-03 |
| Kaye Edward M. MD | Sale | -12,126 | $18.24 | $221,154 | 2025-08-20 |
| Allan Jonathan | Sale | -1,683 | $18.24 | $30,695 | 2025-08-20 |
| Ticho Barry | Sale | -2,805 | $18.24 | $51,158 | 2025-08-20 |
| Allan Jonathan | Derivatives Exercise | 6,000 | 2025-08-18 | ||
| Kaye Edward M. MD | Derivatives Exercise | 26,250 | 2025-08-18 | ||
| Ticho Barry | Derivatives Exercise | 10,000 | 2025-08-18 | ||
| Allan Jonathan | Sale | -13,712 | $15 | $205,680 | 2025-08-15 |
| Ticho Barry | Sale | -4,504 | $12.82 | $57,724 | 2025-08-05 |
| Ticho Barry | Sale | -4,503 | $11.63 | $52,379 | 2025-07-02 |
| LEVIN ARTHUR A | Derivatives Exercise | 1,210 | 2025-07-02 | ||
| Hoitt Jason | Initial | 2025-06-23 | |||
| Skorpios Trust | Sale | -3,000,000 | $10.2 | $30,600,000 | 2025-06-06 |
| Ticho Barry | Sale | -8,216 | $10 | $82,160 | 2025-06-04 |
| Ticho Barry | Sale | -26,631 | $10 | $266,310 | 2025-05-05 |
| LEVIN ARTHUR A | Derivatives Exercise | 1,210 | 2025-04-02 | ||
| Kaye Edward M. MD | Sale | -19,289 | $8.67 | $167,236 | 2025-03-20 |
| Ticho Barry | Sale | -7,217 | $8.67 | $62,571 | 2025-03-20 |
| Allan Jonathan | Sale | -4,211 | $8.67 | $36,509 | 2025-03-20 |
| Allan Jonathan | Derivatives Exercise | 13,475 | 2025-03-18 | ||
| Kaye Edward M. MD | Derivatives Exercise | 61,750 | 2025-03-18 | ||
| Ticho Barry | Derivatives Exercise | 23,100 | 2025-03-18 | ||
| Kaye Edward M. MD | Derivatives Exercise | 35,000 | 2025-01-02 | ||
| Skorpios Trust | Sale | -2,000,000 | $11.5 | $23,000,000 | 2024-12-27 |
| Allan Jonathan | Sale | -13,666 | $13.69 | $187,057 | 2024-12-11 |
| Ticho Barry | Sale | -2,586 | $12.99 | $33,596 | 2024-12-11 |
| Kaye Edward M. MD | Sale | -6,786 | $12.99 | $88,158 | 2024-12-11 |
| Allan Jonathan | Sale | -9,696 | $12.78 | $123,891 | 2024-12-10 |
| Kaye Edward M. MD | Sale | -6,170 | $12.78 | $78,837 | 2024-12-10 |
| Kaye Edward M. MD | Derivatives Exercise | 26,250 | 2024-12-10 | ||
| Ticho Barry | Sale | -13,945 | $12.78 | $178,182 | 2024-12-10 |
| Allan Jonathan | Derivatives Exercise | 6,000 | 2024-12-05 | ||
| Kaye Edward M. MD | Derivatives Exercise | 26,500 | 2024-12-05 | ||
| Ticho Barry | Derivatives Exercise | 10,000 | 2024-12-05 | ||
| Kaye Edward M. MD | Derivatives Exercise | 21,591 | 2024-12-03 | ||
| Ticho Barry | Sale | -10,000 | $12.07 | $120,698 | 2024-12-03 |
| Ticho Barry | Derivatives Exercise | 58,792 | 2024-12-03 | ||
| Allan Jonathan | Derivatives Exercise | 33,927 | 2024-12-03 | ||
| Ticho Barry | Sale | -10,000 | $12.68 | $126,803 | 2024-11-05 |
| Ticho Barry | Derivatives Exercise | 10,000 | 2024-11-05 | ||
| Ticho Barry | Sale | -10,000 | $12.06 | $120,648 | 2024-10-02 |
| Ticho Barry | Derivatives Exercise | 10,000 | 2024-10-02 | ||
| Skorpios Trust | Sale | -1,937,500 | $14.05 | $27,221,875 | 2024-09-23 |
| Ticho Barry | Sale | -10,000 | $14.92 | $149,187 | 2024-09-05 |
| Ticho Barry | Derivatives Exercise | 10,000 | 2024-09-05 | ||
| Ticho Barry | Sale | -10,000 | $14.58 | $145,843 | 2024-08-05 |
| Ticho Barry | Derivatives Exercise | 10,000 | 2024-08-05 | ||
| Nash Huw M. | Sale | -2,500 | $13.1 | $32,753 | 2024-07-03 |
| Ticho Barry | Sale | -10,000 | $13.75 | $137,458 | 2024-07-03 |
| Ticho Barry | Derivatives Exercise | 10,000 | 2024-07-03 | ||
| Ticho Barry | Sale | -10,000 | $15.21 | $152,127 | 2024-06-05 |
| Ticho Barry | Derivatives Exercise | 10,000 | 2024-06-05 | ||
| Nash Huw M. | Sale | -50,000 | $15.39 | $769,500 | 2024-05-22 |
| Nash Huw M. | Derivatives Exercise | 50,000 | 2024-05-22 | ||
| Kaye Edward M. MD | Sale | -42,350 | $15.39 | $651,783 | 2024-05-22 |
| Allan Jonathan | Sale | -8,599 | $15.04 | $129,327 | 2024-05-22 |
| Allan Jonathan | Derivatives Exercise | 8,599 | 2024-05-22 | ||
| Ticho Barry | Sale | -10,000 | $11.37 | $113,653 | 2024-05-03 |
| Ticho Barry | Derivatives Exercise | 10,000 | 2024-05-03 | ||
| Skorpios Trust | Sale | -3,600,000 | $11.6 | $41,760,000 | 2024-04-18 |
| Ticho Barry | Sale | -9,426 | $13.23 | $124,684 | 2024-04-03 |
| Ticho Barry | Derivatives Exercise | 442 | 2024-04-03 | ||
| Nash Huw M. | Sale | -61,329 | $13.22 | $811,058 | 2024-04-03 |
| Nash Huw M. | Derivatives Exercise | 50,000 | 2024-04-03 | ||
| Allan Jonathan | Sale | -5,126 | $13.19 | $67,606 | 2024-04-01 |
| Nash Huw M. | Sale | -4,116 | $6.1 | $25,102 | 2024-03-19 |
| Nash Huw M. | Derivatives Exercise | 13,100 | 2024-03-19 | ||
| Tulipano Stephen J | Sale | -4,116 | $6.1 | $25,102 | 2024-03-19 |
| Tulipano Stephen J | Derivatives Exercise | 13,100 | 2024-03-19 | ||
| Ticho Barry | Sale | -4,116 | $6.1 | $25,102 | 2024-03-19 |
| Ticho Barry | Derivatives Exercise | 13,100 | 2024-03-19 | ||
| Kaye Edward M. MD | Sale | -11,150 | $6.1 | $67,999 | 2024-03-19 |
| Kaye Edward M. MD | Derivatives Exercise | 35,500 | 2024-03-19 | ||
| Allan Jonathan | Sale | -2,349 | $6.1 | $14,326 | 2024-03-19 |
| Allan Jonathan | Derivatives Exercise | 7,475 | 2024-03-19 | ||
| Ticho Barry | Sale | -10,000 | $7.75 | $77,469 | 2024-03-05 |
| Ticho Barry | Derivatives Exercise | 5,504 | 2024-03-05 | ||
| TZIANABOS ARTHUR | Derivatives Exercise | 31,739 | 2024-02-15 | ||
| Ticho Barry | Sale | -10,000 | $4.8 | $47,991 | 2024-02-05 |
| Ticho Barry | Sale | -10,000 | $5.74 | $57,352 | 2024-01-04 |
The information provided in this report about STOK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Stoke Therapeutics, Inc(NASDAQ:STOK) 
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary ribonucleic acid therapeutics platform, Targeted Augmentat...
Website: http://www.stoketherapeutics.com
Founded: 2015
IPO Price: $18 (Jun 19, 2019)
Full Time Employees: 56
CEO: Edward M. Kaye
Sector: Healthcare
Industry: Biotechnology